Sun Pharma Share Price
- All
- News
-
Why Are Pharma Stocks Rising?
The recent decline in the stock market has unnerved investors and traders alike. But pharma stocks are rising. Find out why and other implications.
-
Sun Pharma Shares Tank Over 4% After Q4 Earnings
Shares of Sun Pharmaceutical Industries fell by over 4 per cent in morning trade on Tuesday a day after the company said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss.
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Sun Pharma Slides Over 4% Post March Quarter Results
Sun Pharma posted a net profit to Rs 894 crore in the fourth quarter ended March 2021, which is a rise of 124 per cent compared to the same quarter last year
-
Sun Pharma To Make Eli Lilly's Covid Medicine In India; Shares Gain
Sun Pharmaceutical shares rose as much as 3.51% to hit an intraday high of Rs 703.40 after it signed an agreement with Eli Lilly to make baricitinib.
-
Sensex, Nifty Set To Open Marginally Lower; ITC, Sun Pharma In Focus
ITC, the country's largest cigarette maker will be in focus after it reported that its annual net profit declined 12 per cent to Rs 3,663 crore
-
Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US
The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.
-
Sun Pharma Acquires Canada's Aquinox Pharma For $8.2 Million, Shares Gain
Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.
-
Sun Pharma Q2 Profit At Rs 1,064 Crore, Shares Jump Over 3%
On the BSE, the Sun Pharma stock jumped as much as 3.15 per cent to Rs 441.00 apiece after the earnings announcement.
-
Sebi Orders Forensic Audit Of Sun Pharma's Accounts; Shares Plunge
On the Bombay Stock Exchange (BSE), Sun Pharma declined as much as 4.01 per cent to an intraday low of Rs 414.60 apiece.
-
Sun Pharma Surges On Agreement To Sell Generic Drugs In China
Sun Pharma has entered into an agreement with China Medical System Holdings to develop and commercialize seven generic products in Mainland China.
-
Sun Pharma Profit Up 31% At Rs 1,387 Crore In June Quarter, Shares Jump Over 5%
Shares in Sun Pharma jumped as much as 5.43 per cent after the earnings announcement.
-
Buy Canfin Homes; Sell Sun Pharma, Cholamandalam: Choice Broking
Share Market News: Choice Broking recommends selling Sun Pharma shares in the range of Rs 429 and up to Rs 432 for downside target of Rs 412 with stop loss at Rs 438.
-
Sensex, Nifty End Flat; Titan, UPL Fall, Indian Oil, Bajaj Finance Gain
The S&P BSE Sensex and NSE Nifty 50 Index ended on a flat note as gains in Bajaj Finance and Sun Pharma were offset by losses in Titan and TCS.
-
Sensex Falls Over 350 Points, Nifty Slides To 10,620: 10 Things To Know
Domestic equity benchmarks extended losses with the S&P BSE Sensex falling for seventh session in a row and NSE Nifty 50 Index logging in sixth session of decline paced by losses in Dr. Reddy's Labs, JSW Steel, Sun Pharma, Hindalco and Vedanta. Meanwhile, weak Asian markets also added to the selling pressure in India after U.S. retail sales fell 1....
-
Why Are Pharma Stocks Rising?
The recent decline in the stock market has unnerved investors and traders alike. But pharma stocks are rising. Find out why and other implications.
-
Sun Pharma Shares Tank Over 4% After Q4 Earnings
Shares of Sun Pharmaceutical Industries fell by over 4 per cent in morning trade on Tuesday a day after the company said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss.
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Sun Pharma Slides Over 4% Post March Quarter Results
Sun Pharma posted a net profit to Rs 894 crore in the fourth quarter ended March 2021, which is a rise of 124 per cent compared to the same quarter last year
-
Sun Pharma To Make Eli Lilly's Covid Medicine In India; Shares Gain
Sun Pharmaceutical shares rose as much as 3.51% to hit an intraday high of Rs 703.40 after it signed an agreement with Eli Lilly to make baricitinib.
-
Sensex, Nifty Set To Open Marginally Lower; ITC, Sun Pharma In Focus
ITC, the country's largest cigarette maker will be in focus after it reported that its annual net profit declined 12 per cent to Rs 3,663 crore
-
Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US
The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.
-
Sun Pharma Acquires Canada's Aquinox Pharma For $8.2 Million, Shares Gain
Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.
-
Sun Pharma Q2 Profit At Rs 1,064 Crore, Shares Jump Over 3%
On the BSE, the Sun Pharma stock jumped as much as 3.15 per cent to Rs 441.00 apiece after the earnings announcement.
-
Sebi Orders Forensic Audit Of Sun Pharma's Accounts; Shares Plunge
On the Bombay Stock Exchange (BSE), Sun Pharma declined as much as 4.01 per cent to an intraday low of Rs 414.60 apiece.
-
Sun Pharma Surges On Agreement To Sell Generic Drugs In China
Sun Pharma has entered into an agreement with China Medical System Holdings to develop and commercialize seven generic products in Mainland China.
-
Sun Pharma Profit Up 31% At Rs 1,387 Crore In June Quarter, Shares Jump Over 5%
Shares in Sun Pharma jumped as much as 5.43 per cent after the earnings announcement.
-
Buy Canfin Homes; Sell Sun Pharma, Cholamandalam: Choice Broking
Share Market News: Choice Broking recommends selling Sun Pharma shares in the range of Rs 429 and up to Rs 432 for downside target of Rs 412 with stop loss at Rs 438.
-
Sensex, Nifty End Flat; Titan, UPL Fall, Indian Oil, Bajaj Finance Gain
The S&P BSE Sensex and NSE Nifty 50 Index ended on a flat note as gains in Bajaj Finance and Sun Pharma were offset by losses in Titan and TCS.
-
Sensex Falls Over 350 Points, Nifty Slides To 10,620: 10 Things To Know
Domestic equity benchmarks extended losses with the S&P BSE Sensex falling for seventh session in a row and NSE Nifty 50 Index logging in sixth session of decline paced by losses in Dr. Reddy's Labs, JSW Steel, Sun Pharma, Hindalco and Vedanta. Meanwhile, weak Asian markets also added to the selling pressure in India after U.S. retail sales fell 1....
